The management and outcome of women with post-hydatidiform mole low-risk gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l-1

British Journal of Cancer

Volumn 102, Issue 5, 2010, Pages 810-814

  McGrath, S ^a   Short, D ^a   Harvey, R ^a   Schmid, P ^a   Savage, P M ^a   Seckl, M J ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Chemotherapy; GTN; HCG

Indexed keywords

CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYDATIDIFORM MOLE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONOTHERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; NEOPLASM STAGING; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77649272230     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605529     Document Type: Article

References (24)

1. Bagshawe KD (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38: 1373-1385
2. Bagshawe KD, Dent J, Newlands ES, Begent RG, Rustin GJ (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96: 795-802
3. Berkowitz RS, Goldstein DP, Bernstein MR (1982) Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease. Cancer 50: 2024-2027
4. Bolis G, Colombo N, Epis A, Mangili G, Vassena L, Vergadoro F, Belloni C (1987) Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor. Tumori 73: 309-313
5. Bolis G, Bonazzi C, Landoni F, Mangili G, Vergadoro F, Zanaboni F, Mangioni C (1988) EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 31: 439-444
6. Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M, Bagshawe KD (1998) Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 34: 1204-1207
7. Chen LM, Lengyel ER, Bethan Powell C (2004) Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia. Gynecol Oncol 94: 204-207
8. Gilani MM, Yarandi F, Eftekhar Z, Hanjani P (2005) Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia. Aust N Z J Obstet Gynaecol 45: 161-164
9. Gleeson NC, Finan MA, Fiorica JV, Robert WS, Hoffman MS, Wilson J (1993) Nonmetastatic gestational trophoblastic disease. Weekly metho-trexate compared with 8-day methotrexate-folinic acid. Eur J Gynaecol Oncol 14: 461-465
10. Kim SJ, Lee C, Kwon SY, Na YJ, Oh YK, Kim CJ (2004) Studying changes in the incidence, diagnosis and management of GTD: the South Korean model. J Reprod Med 49: 643-654
11. Kohorn EI, Goldstein DP, Hancock BW, Kim SJ, Lurain JR, Newlands E, Soper JT, Wong LC (2000) Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int J Gynaecol Cancer 10: 84-88
12. McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES (2002) Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20: 1838-1844
13. Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Holden L (1991) Results with the EMA/CO (etoposide, methotrexate, actinomycin-D, cyclophosphamide, vincristine) regimen in high-risk gestational tropho-blastic tumours, 1979 to 1989. Br J Obstet Gynaecol 98: 550-557
14. Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJS (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational tropho-blastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18: 854-859
15. Ngan S, Seckl MJ (2007) Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol 19: 486-491
16. Osborne R, Filiaci V, Schink J, Mannel R, Provencher D, Alvarez-Secord A, Kelley J, Lage J, Schilder J, Miller D (2008) A randomized phase III trial comparing weekly parenteral methotrexate and 'pulse' dactinomycin as primary management for low-risk gestational trophoblastic neoplasia: A Gynecologic Oncology Group study. Gynecol Oncol 108: S2-S3 (Abstract #2)
17. Pezeshki M, Hancock BW, Silcocks P, Everard JE, Coleman J, Gillespie AM, Tidy J, Coleman RE (2004) The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol 95: 423-429
18. Rustin GJS, Newlands ES, Lutz JM, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S, Short D (1996) Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumours increases the incidence of second tumours. J Clin Oncol 14: 2769-2773
19. Savage P, Seckl MJ (2005) The role of repeat uterine evacuation in trophoblast disease. Gynecol Oncol 99: 251-252
20. Sebire NJ, Seckl MJ (2008) Gestational trophoblastic disease: current management of hydatidiform mole. BMJ 337: a1193
21. Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356: 36-39
22. Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, Kose MF (2006) Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblas-tic neoplasia. Int J Gynecol Cancer 16: 1432-1438
23. Wang J, Short D, Sebire NJ, Lindsay I, Newlands ES, Schmid P, Savage PM, Seckl MJ (2008) Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/ cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol 19: 1578-1583
24. Yarandi F, Eftekhar Z, Shojaei H, Kanani S, Sharifi A, Hanjani P (2008) Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia. Int J Gynaecol Obstet 103: 33-37